Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ORL J Otorhinolaryngol Relat Spec ; 62(4): 199-203, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10859520

RESUMO

Squamous cell carcinoma is the most common malignant neoplasm of the larynx. One of the most important influences on prognosis is the presence of metastases to the cervical lymph nodes. Accurate determination of lymph node involvement is therefore a prerequisite for individualized therapy in patients with squamous cell carcinoma of the larynx. Clinical palpation of the neck is not very accurate and the role of imaging techniques such as ultrasound, ultrasound-guided fine needle aspiration cytology, color Doppler ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography is being applied in order to improve upon the results of clinical investigation alone. According to our investigations and review of the literature, the accuracy of computed tomography scanning (84.9%) and magnetic resonance imaging (85%) was superior to palpation (69.7%) and ultrasound (72.7%). Ultrasound-guided fine needle aspiration cytology showed an accuracy of 89% and was in the same range with positron emission tomography (90.5%).


Assuntos
Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/secundário , Neoplasias Laríngeas/patologia , Metástase Linfática/diagnóstico , Biópsia por Agulha , Humanos , Linfonodos/diagnóstico por imagem , Linfonodos/patologia , Imageamento por Ressonância Magnética , Pescoço , Segunda Neoplasia Primária , Tomografia Computadorizada de Emissão , Tomografia Computadorizada por Raios X , Ultrassonografia Doppler em Cores
2.
Laryngorhinootologie ; 78(10): 573-8, 1999 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-10595343

RESUMO

BACKGROUND: Glucocorticoids are widely used in medicine. Within the last few years, however, patients have become very suspicious of corticoids. The attending physicians frequently has to use a great deal of persuasion prior to applying this very effective and often indispensable group of medication. PATIENTS: We report on four patients who developed allergic reactions (i.e. erythema in face and on body, itching, flushing, drop in blood pressure, respiratory distress, cold sweats, etc.) immediately after intravenous administration of prednisolone-21 hydrogen succinate (Solu-Decortin H, SDH). RESULTS: Three out of four patients had a positive reaction to an intracutaneous test with SDH, but no reaction to the additive sodium succinate. The prick test was negative in all patients. No specific IgE antibodies were detected in the serum of these patients. However allergic reaction to SDH must be presumed in at least three cases as it is difficult to detect glucocorticoid antibodies in serum and standardizes techniques are lacking. One female patient had a cross-reaction to prednisolon and dexamethasone. A renewed application of SDH was tolerated well by all patients when H1- and H2-receptors were blocked and calcium was administered to stabilize membranes. CONCLUSIONS: Allergic reactions after glucocorticosteroid therapy are only occasionally mentioned in literature, appear more often when the agent is applied topically, and may lead to dangerous complications in patients if administered intravenously. Therefore, when allergic reactions result from glucocorticoid therapy (immediate reactions should be suspect), corticosteroid allergy should be considered as a differential diagnosis.


Assuntos
Toxidermias/etiologia , Hipersensibilidade a Drogas/etiologia , Glucocorticoides/efeitos adversos , Prednisolona/análogos & derivados , Administração Tópica , Sistemas de Notificação de Reações Adversas a Medicamentos , Idoso , Reações Cruzadas , Toxidermias/imunologia , Hipersensibilidade a Drogas/imunologia , Feminino , Glucocorticoides/administração & dosagem , Glucocorticoides/imunologia , Perda Auditiva Súbita/tratamento farmacológico , Perda Auditiva Súbita/imunologia , Humanos , Imunoglobulina E/sangue , Infusões Intravenosas , Testes Intradérmicos , Doença de Meniere/tratamento farmacológico , Doença de Meniere/imunologia , Pessoa de Meia-Idade , Prednisolona/administração & dosagem , Prednisolona/efeitos adversos , Prednisolona/imunologia , Fatores de Risco
3.
Arch Otolaryngol Head Neck Surg ; 125(12): 1322-8, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10604409

RESUMO

BACKGROUND: Accurate determination of lymph node involvement is a prerequisite for individualized therapy in patients with squamous cell carcinoma of the head and neck region. In a previous study, we showed that positron emission tomography (PET) with fluorodeoxyglucose F 18 with and without attenuation correction is superior to magnetic resonance imaging for this purpose in a scientific setting. OBJECTIVE: To evaluate the diagnostic accuracy of a shortened PET protocol (acquisition time, 20 minutes) in a routine clinical setting. DESIGN: The results of static, nonattenuation-corrected PET performed on patients in 2 bed positions starting 40 minutes after the intravenous injection of 370 MBq of fluorodeoxyglucose F 18 and the results of morphologic procedures (computed tomography and magnetic resonance imaging) were compared prospectively in 70 patients for lymph node staging. Postoperative pathologic findings served as a criterion standard. SETTING: An academic medical center. RESULTS: The diagnostic accuracy of PET for detecting "neck sides" with malignant involvement was superior to morphologic procedures, with a sensitivity and specificity of 87% and 94%, respectively, compared with computed tomographic values of 65% and 47% and magnetic resonance imaging values of 88% and 41%, respectively. CONCLUSION: A short PET protocol that is suitable for routine clinical use is superior to morphologic procedures (computed tomography and magnetic resonance imaging) for the detection of lymph node involvement in head and neck squamous cell carcinomas.


Assuntos
Carcinoma de Células Escamosas/patologia , Fluordesoxiglucose F18 , Neoplasias de Cabeça e Pescoço/patologia , Linfonodos/diagnóstico por imagem , Linfonodos/patologia , Tomografia Computadorizada de Emissão/métodos , Centros Médicos Acadêmicos , Adulto , Idoso , Carcinoma de Células Escamosas/cirurgia , Terapia Combinada , Feminino , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Excisão de Linfonodo , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Pescoço/diagnóstico por imagem , Pescoço/patologia , Sensibilidade e Especificidade , Tomografia Computadorizada por Raios X
4.
Cancer ; 85(11): 2305-14, 1999 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-10357398

RESUMO

BACKGROUND: Extramedullary plasmacytoma (EMP) is a rare entity belonging to the category of non-Hodgkin lymphoma. EMPs make up 4% of all plasma cell tumors and occur mainly in the upper aerodigestive tract (UAD). Seven patients with EMP included in this evaluation were under the authors' care and have been clinically followed since 1990. Because there are no general guidelines for the treatment of patients with EMP, the authors tried to obtain detailed data about the occurrence of this disease and also reviewed the therapies that have been used. To do so, they evaluated all EMP cases published in the medical literature until now and included their own experience. METHODS: Based on the clinical course and follow-up of their own EMP patients, the authors evaluated and reinvestigated all EMP cases cited in MEDLINE, Index Medicus, DIMDI (Deutsches Institut fur medizinische Dokumentation und Information, Cologne, Germany), and the reference lists of the publications found through these sources. RESULTS: In a detailed literature search, more than 400 publications between 1905 and 1997 were found, and these revealed that EMP mainly occurs between the fourth and seventh decades of life. Seven hundred fourteen cases (82.2%) were found in the UAD, and 155 cases (17.8%) were found in other body regions. The following therapeutic strategies were used to treat patients with EMP of the UAD: radiation therapy alone in 44.3%, combined therapy (surgery and radiation) in 26.9%, and surgery alone in 21.9%. The median overall survival or recurrence free survival was longer than 300 months for patients who underwent combined intervention (surgery and radiation). This result was statistically highly significant (P = 0.0027, log rank test) compared with the results for patients who underwent surgical intervention alone (median survival time, 156 months) or radiation therapy alone (median survival time, 144 months). In most cases of non-UAD EMP, surgery was performed (surgery alone, 55.6%; surgery and radiation combined, 19.8%; radiation alone, 11.1%), but there were no statistical differences in survival (P = 0.62). Overall, after treatment for EMP in the UAD, 61.1% of all patients had no recurrence or conversion to systemic involvement (i.e., multiple myeloma, MM); however, 22.0% had recurrence of EMP, and 16.1% had conversion to MM. After treatment for EMP in non-UAD areas, 64.7% of all patients had no recurrence or MM, 21.2% had recurrence, and 14.1% had conversion to MM. CONCLUSIONS: The current investigation provides evidence that surgery alone gives the best results in cases of EMP of the UAD when resectability is good. However, if complete surgical tumor resection is doubtful or impossible and/or if lymph node areas are affected, then combined therapy (surgery and radiation) is recommended. These results, which were obtained from retrospective studies, should be confirmed in randomized trials comparing surgery with combined radiation therapy and surgery.


Assuntos
Neoplasias de Cabeça e Pescoço/epidemiologia , Plasmocitoma/epidemiologia , Adulto , Idoso , Terapia Combinada , Neoplasias de Cabeça e Pescoço/patologia , Neoplasias de Cabeça e Pescoço/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Plasmocitoma/patologia , Plasmocitoma/terapia , Estudos Retrospectivos , Taxa de Sobrevida
5.
Arch Otolaryngol Head Neck Surg ; 124(11): 1260-4, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9821930

RESUMO

OBJECTIVE: To describe patients who developed allergic reactions (ie, erythema on their face and body, itching, flushing, drop in blood pressure, respiratory distress, and cold sweats) immediately after intravenous injection of prednisolone hemisuccinate (SoluDecortin H, E Merck, Darmstadt, Germany). SETTING: Academic medical center. RESULTS: Three of 4 patients had a positive reaction to an intracutaneous test with prednisolone hemisuccinate (SoluDecortin H) but no reaction to the additive sodium succinate. The results of the prick test were negative for all patients. Although no specific IgE antibodies were detected in the serum of these patients, allergic reaction was noted in 3 cases, since standardized techniques to detect antibodies in the serum for hydrocortisone acetate (ie, prednisolone) are lacking. One female patient had a cross-reaction to prednisolone and dexamethasone (Fortecortin, E Merck, Darmstadt, Germany). A renewed application of prednisolone hemisuccinate was well tolerated by all patients when histamine1 and histamine2 receptors were blocked with the use of cimetidine hydrochloride, 200 mg twice per day (1-0-1 ampules, Tagamet, SmithKline Beecham Pharmaceuticals, Philadelphia, Pa) and dimethindene maleate, 4 mg twice per day (1-0-1 ampules, Fenistil, Novartis, Munich, Germany); calcium was given for membrane stabilization. CONCLUSIONS: Allergic reactions to glucocorticoid therapy are only occasionally mentioned in the literature. These reactions appear more often when glucocorticoids are applied topically and may lead to dangerous complications in patients if administered systemically. Therefore, when allergic reactions result from glucocorticoid therapy, (immediate-type reactions should be suspect), consider corticosteroid allergy as a differential diagnosis.


Assuntos
Toxidermias/etiologia , Hipersensibilidade a Drogas/etiologia , Glucocorticoides/efeitos adversos , Prednisolona/análogos & derivados , Adulto , Idoso , Reações Cruzadas , Dexametasona/administração & dosagem , Dexametasona/efeitos adversos , Feminino , Glucocorticoides/administração & dosagem , Humanos , Imunoglobulina E/sangue , Injeções Intravenosas , Testes Intradérmicos , Masculino , Pessoa de Meia-Idade , Prednisolona/administração & dosagem , Prednisolona/efeitos adversos
6.
Artigo em Inglês | MEDLINE | ID: mdl-9519383

RESUMO

Esophagorespiratory fistulae at the adult age can develop through malignant tumor growth, endoscopy, bougienage, laser therapy, or through a radiochemotherapy. We report a female patient with inoperable bronchial cancer, who developed a symptomatic esophagorespiratory fistula during radiochemotherapy with cisplatin. At first, conventional plastic tubes and then novel selfexpanding silicone-coated Gianturco-Song stents were used in an unsuccessful attempt to close the fistula. After the extraction of two Gianturco-Song stents, the insertion of a Montgomery-Salivary bypass stent in the esophagus and a dynamic stent in the trachea resulted in a permanent occlusion of the fistula. This case demonstrates that Montgomery-Salivary bypass stents do not tend to migrate due to their characteristic shape and self-fixation, and that the novel self-expanding, silicone coated Gianturco-Song stents can be extracted with rigid endoscopy if necessary.


Assuntos
Falha de Prótese , Implantação de Prótese , Stents , Fístula Traqueoesofágica/cirurgia , Adulto , Esôfago/diagnóstico por imagem , Feminino , Humanos , Radiografia , Fatores de Tempo
7.
Z Gastroenterol ; 35(4): 277-83, 1997 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-9221611

RESUMO

Esophagorespiratory fistulas were frequently caused by malignant tumors, bougienage, laser therapy or radiochemotherapy. We here report the case of a patient with inoperable bronchial cancer, who developed a symptomatic esophagorespiratory fistula during combined radiochemotherapy with Cisplatin. A sufficient occlusion of the fistula could not be achieved with conventional plastic tubes or novel self-expanding silicone-coated Gianturco Song stents. After extraction of two Gianturco Song stents we inserted a Montgomery Salivary Bypass Stent into the esophagus and Dynamic stent into the trachea. This resulted in a total occlusion of the fistula. This present case suggests that the Montgomery stent may have little tendency to migrate due to its characteristic configuration and fixation and further demonstrates that the novel self-expanding silicone-coated Gianturco Song stents can be removed, if necessary.


Assuntos
Adenocarcinoma/terapia , Fístula Brônquica/terapia , Carcinoma Broncogênico/terapia , Neoplasias Pulmonares/terapia , Stents , Fístula Traqueoesofágica/terapia , Adenocarcinoma/diagnóstico por imagem , Adulto , Fístula Brônquica/diagnóstico por imagem , Carcinoma Broncogênico/diagnóstico por imagem , Terapia Combinada , Feminino , Humanos , Neoplasias Pulmonares/diagnóstico por imagem , Desenho de Prótese , Falha de Prótese , Radiografia , Recidiva , Fístula Traqueoesofágica/diagnóstico por imagem
8.
Dysphagia ; 12(2): 79-83, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9071807

RESUMO

Patients with hypopharyngeal and cervical esophageal strictures and fistulas caused by advanced malignancy, ingestion of caustic material, or following surgery or radiation therapy often suffer from marked dysphagia. In such cases the implantation of a Montgomery Salivary Bypass Tube (MSBT) can be an effective therapeutic option to bridge the fistulous tract or bypass a stenosis. Being able to eat and drink without the need for intravenous supplementation or nasogastric or gastrostomy tube feeding in general greatly improves the patient's quality of life. Since 1981 we have successfully inserted the MSBT in 44 cases suffering from dysphagia of different etiology. Our experiences with the indications for implantation, insertion techniques, and postoperative results are presented. Three selected cases of progressive dysphagia in which the MSBT is demonstrated to be the treatment of choice are described in more detail. In one case, a tracheoesophageal fistula and in another a stricture of the upper esophageal sphincter (UES) were bypassed so that oral intake of soft food became possible again. The third patient suffered from a disturbance of the esophageal motility after resection of a Hippel-Lindau tumor in the spinal cord and syringe drainage; even swallowing saliva was impeded. After insertion of a MSBT, uncomplicated soft food intake became possible again.


Assuntos
Transtornos de Deglutição/reabilitação , Intubação , Saliva/fisiologia , Adulto , Idoso , Transtornos de Deglutição/etiologia , Estenose Esofágica/reabilitação , Feminino , Humanos , Cuidados Paliativos , Stents , Fístula Traqueoesofágica/reabilitação
9.
Artigo em Inglês | MEDLINE | ID: mdl-9166876

RESUMO

Over the course of 18 months 359 patients with defined acute and chronic inner ear disorders who had not responded to treatment with medication were given hyperbaric oxygen (HBO) therapy. The inner ear diseases of the patients were divided, based on the duration of their conditions, into four symptomatic groups. Of the patients who had had hearing loss for less than 3 months, noticeable improvement or complete recovery was seen in 13% (20 dB in at least three test frequencies); 25.2% showed an improvement between 10 and 20 dB. Changes up to 10 dB or less were not considered to be positive. Patients with a pretreated hearing loss for more than 3 months had markedly less benefit from HBO therapy. Two percent regained normal hearing function. In 30% an improvement of more than 10 dB was achieved. For patients who had suffered from tinnitus for less than 3 months excellent improvement was seen in 6.7% and noticeable improvement in 44.3% expressed by means of a visual analog scale. In 44.3% the tinnitus was described as unchanged. Patients who had had tinnitus for more than 3 months before HBO therapy showed a less favorable response to HBO. In none of the patients did the tinnitus disappear; 34.4% of the patients described a noticeable improvement in their complaints.


Assuntos
Doenças Cocleares/terapia , Transtornos da Audição/etiologia , Oxigenoterapia Hiperbárica/normas , Zumbido/etiologia , Doença Aguda , Adolescente , Adulto , Audiometria , Criança , Doença Crônica , Doenças Cocleares/classificação , Doenças Cocleares/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento
10.
J Nucl Med ; 36(10): 1747-57, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7562038

RESUMO

UNLABELLED: Accurate, preoperative assessment of tumor extent and lymph node involvement is mandatory for individualized therapy in patients with squamous-cell carcinomas (SCCs) of the head and neck region. Metabolic imaging, [18F]fluorodeoxyglucose (FDG) PET and MRI were compared with postoperative, histologic tissue characterization. METHODS: Dynamic and static PET with 370 MBq [18F]FDG up to 60 min postinjection and MRI were compared prospectively in 22 patients with head and neck SCCs. PET results with and without attenuation correction were compared with postoperative T and N stages based on pathologic findings. RESULTS: Kinetic characteristics and tracer uptake intensity were similar in primary tumors and lymph node metastases. In both, FDG uptake did not reach a plateau phase 60 min postinjection. There was no statistically significant correlation of FDG uptake with plasma glucose level or histologic grading. All primary tumors were clearly demonstrated by PET, which tended to overestimate tumor size. The sensitivity and specificity for detecting individual lymph node involvement were 90% and 96%, respectively, for PET and, thus, significantly higher for MRI (78% and 71%, respectively; p < 0.05). N stages were correctly identified by MRI in only 4 patients; PET correctly staged lymph nodes in 15 of 17 patients. Based on "neck sides", the sensitivity and specificity were higher for PET, 89% and 100%, respectively, compared with MRI values of 72% and 56%, respectively. CONCLUSION: FDG-PET may be helpful in detecting occult primary tumors with positive lymph nodes.


Assuntos
Carcinoma de Células Escamosas/patologia , Desoxiglucose/análogos & derivados , Radioisótopos de Flúor , Neoplasias Hipofaríngeas/patologia , Neoplasias Orofaríngeas/patologia , Tomografia Computadorizada de Emissão , Adulto , Idoso , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/diagnóstico por imagem , Endoscopia , Feminino , Fluordesoxiglucose F18 , Humanos , Neoplasias Hipofaríngeas/diagnóstico , Neoplasias Hipofaríngeas/diagnóstico por imagem , Metástase Linfática , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Neoplasias Orofaríngeas/diagnóstico , Neoplasias Orofaríngeas/diagnóstico por imagem , Valor Preditivo dos Testes , Sensibilidade e Especificidade
12.
Laryngorhinootologie ; 73(1): 21-6, 1994 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-7908199

RESUMO

The development of a radiolabelled somatostatin analogue Indium-111-Pentetreotide makes the detection of somatostatin receptor-bearing tumours by scintigraphic techniques possible. The existence of high-affinity binding sites for somatostatin has been described previously for most endocrine active tumours of the gastroenteropancreatic system (GEP), malignant lymphomas, small cell lung carcinomas, a subgroup of breast tumours and several types of neuroendocrine related human tumours. Using this new diagnostic tool we investigated some head and neck tumours of neuroendocrine origin (carcinoid of larynx, Merkel cell carcinoma, paragangliomas) with the newly developed radiolabelled somatostatin analogue Indium-111-Pentetreotide whether in vivo visualisation of somatostatin receptors might be possible. In cases not accessible for surgery but with a positive receptor status we started a specific therapy with the somatostatin analogue octreotide. The preliminary results suggest that this new isotopic scanning technique in a diagnostic tool and a predictive method for an effective therapy of those head and neck tumours which revealed highly specifically a positive receptor status. The therapeutical results using the somatostatin analogue octreotide indicate that this new concept is an ideal therapeutic strategy for those neuroendocrine head and neck tumours which cannot be controlled by surgical procedures.


Assuntos
Neoplasias de Cabeça e Pescoço/diagnóstico por imagem , Receptores de Somatostatina/análise , Adulto , Idoso , Idoso de 80 Anos ou mais , Tumor Carcinoide/diagnóstico por imagem , Tumor Carcinoide/tratamento farmacológico , Tumor Carcinoide/fisiopatologia , Carcinoma de Célula de Merkel/diagnóstico por imagem , Carcinoma de Célula de Merkel/tratamento farmacológico , Carcinoma de Célula de Merkel/fisiopatologia , Tumor do Corpo Carotídeo/diagnóstico por imagem , Tumor do Corpo Carotídeo/tratamento farmacológico , Tumor do Corpo Carotídeo/fisiopatologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Feminino , Seguimentos , Tumor Glômico/diagnóstico por imagem , Tumor Glômico/tratamento farmacológico , Tumor Glômico/fisiopatologia , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Neoplasias de Cabeça e Pescoço/fisiopatologia , Humanos , Processamento de Imagem Assistida por Computador , Radioisótopos de Índio , Neoplasias Laríngeas/diagnóstico por imagem , Neoplasias Laríngeas/tratamento farmacológico , Neoplasias Laríngeas/fisiopatologia , Masculino , Pessoa de Meia-Idade , Octreotida/uso terapêutico , Cintilografia , Receptores de Somatostatina/efeitos dos fármacos , Receptores de Somatostatina/fisiologia , Somatostatina/análogos & derivados
14.
Laryngorhinootologie ; 69(1): 35-40, 1990 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-2310458

RESUMO

Otitis media with effusion occurs very frequently in childhood and usually heals without therapy. The condition is thought to be due to a higher susceptibility to infections of the upper respiratory tract and the fact that the Eustachian tube is not yet functioning perfectly at that age. Many authors explain this astonishingly high rate of spontaneous recoveries by tube malfunction alone, never even considering a middle ear clearance system. It is known from the paranasal sinuses that the cavities are regularly and continually cleaned according to very precise rules. In in-vivo experiments with guinea pigs the author proved that there is an obvious similarity between the paranasal sinus and the middle ear as far as the clearance system is concerned. By applying tracer substances to the middle ear mucosa the usual drainage pathways out of the middle ear into the Eustachian tube, and the different rates of drainage were very precisely defined.


Assuntos
Orelha Média/anatomia & histologia , Tuba Auditiva/anatomia & histologia , Ventilação da Orelha Média , Depuração Mucociliar/fisiologia , Animais , Cobaias , Microscopia Eletrônica de Varredura
15.
Laryngorhinootologie ; 68(8): 437-41, 1989 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-2789572

RESUMO

The possibilities of using immunocytes in cancer therapy have been increasing during the last few years. Contrary to the promising results gained by in vitro experiments, several clinical trials have shown that, on the one hand, it is difficult to preserve a quantity of cells big enough to inhibit tumours, and they have also shown that, on the other hand, antitumour lymphocytes do not get into the tumour. That is why we concentrated on improving the tumour selectivity of the antitumour lymphocytes. We carried this out practising two sets of experiments. First we incubated patient lymphocytes with tumour extract and vaccinated them in this manner. Secondly, by binding antitumour antibodies to lymphocytes, we could improve the ability of lymphocytes to bind with tumour cells. We tested these therapy models on human tumours and on tumour cell lines. Both were implanted in the renal capsule space of nude mice.


Assuntos
Sobrevivência Celular , Neoplasias de Cabeça e Pescoço/terapia , Imunização Passiva , Células Matadoras Ativadas por Linfocina/transplante , Ensaio de Cápsula Sub-Renal , Adenocarcinoma/terapia , Idoso , Animais , Carcinoma de Células Escamosas/terapia , Linhagem Celular , Feminino , Humanos , Masculino , Camundongos , Camundongos Nus , Pessoa de Meia-Idade
16.
Laryngol Rhinol Otol (Stuttg) ; 66(12): 631-3, 1987 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-3431311

RESUMO

We measured the mean latency of the stapedius reflex by normal listeners. We observed a prolongation of the latency by patients with operative and histological confirmed neurinoma of the VIII. nerve. Even if the measured stapedius reflex latency considerably varies, this method represents, any way, an important support to BERA to discover tumours of the cerebello-pontine angle.


Assuntos
Músculos/fisiopatologia , Neuroma Acústico/fisiopatologia , Tempo de Reação/fisiologia , Reflexo Acústico , Estapédio/fisiopatologia , Adolescente , Adulto , Idoso , Tronco Encefálico/fisiopatologia , Dominância Cerebral/fisiologia , Potenciais Evocados Auditivos , Feminino , Perda Auditiva Neurossensorial/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Valores de Referência
17.
Laryngol Rhinol Otol (Stuttg) ; 66(12): 653-4, 1987 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-3431314

RESUMO

We use BERA to determine the hearing threshold of children. This examination is most of the time performed on outpatients and often combined with a minor surgery. That's the reason why a sedation has to fulfill following conditions: 1. a quick, non-traumatic induction of anaesthesia--normally--without premedication; 2. an anesthesia deep enough to enable us to carry out a minor surgery as well as to get the best reliable BERA results; 3. a short period of wake-up as the patient should leave the hospital as soon as possible. In short, we got the best results first using Halothane as inhalant for the minor surgery and continuing with Midazolam as i.v. sedative for BERA examination.


Assuntos
Anestesia Geral , Audiometria de Resposta Evocada , Limiar Auditivo , Tronco Encefálico/fisiologia , Anestesia por Inalação , Anestesia Intravenosa , Pré-Escolar , Feminino , Halotano , Humanos , Masculino , Midazolam , Óxido Nitroso
18.
HNO ; 34(8): 346-9, 1986 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-3531107

RESUMO

We report two cases of cervical thorotrastoma. Thorotrast is no longer used as a radiographic contrast agent, so that the rare thorotrastoma is often forgotten in the differential diagnosis of hypopharyngeal tumours. Surgical treatment of a thorotrastoma is not recommenced.


Assuntos
Angiografia , Reação a Corpo Estranho/induzido quimicamente , Granuloma/induzido quimicamente , Hipofaringe/efeitos dos fármacos , Dióxido de Tório/efeitos adversos , Idoso , Doenças das Artérias Carótidas/diagnóstico por imagem , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...